Search Results - Gregory J. Riely

Refine Results
  1. 1
    Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer

    Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer by Gregory J. Riely

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    EGFR: The Paradigm of an Oncogene-Driven Lung Cancer

    EGFR: The Paradigm of an Oncogene-Driven Lung Cancer by Gregory J. Riely, Helena A. Yu

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancers

    Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancers by Helena A. Yu, Gregory J. Riely

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials

    New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials by William D. Travis, Élisabeth Brambilla, Gregory J. Riely

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Targeting ALK: Precision Medicine Takes on Drug Resistance

    Targeting ALK: Precision Medicine Takes on Drug Resistance by W. Marston Linehan, Gregory J. Riely, Alice T. Shaw

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

    Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors by Helena A. Yu, Gregory J. Riely, Christine M. Lovly

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma

    ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma by Jamie E. Chaft, Natasha Rekhtman, Marc Ladanyi, Gregory J. Riely

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma

    KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma by Natasha Rekhtman, Daphne Ang, Gregory J. Riely, Marc Ladanyi, André L. Moreira

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Chemotherapy Definitions and Policies for Thymic Malignancies

    Chemotherapy Definitions and Policies for Thymic Malignancies by Nicolas Girard, Rohit Lal, Heather A. Wakelee, Gregory J. Riely, Patrick J. Loehrer

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?

    Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements? by Darragh Halpenny, Gregory J. Riely, Sara A. Hayes, Helena A. Yu, Junting Zheng, Chaya S. Moskowitz, Michelle S. Ginsberg

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with <i>EGFR</i>-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design

    Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with <i>EGFR</i>-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Cl... by Jamie E. Chaft, Geoffrey R. Oxnard, Camelia S. Sima, Mark G. Kris, Vincent A. Miller, Gregory J. Riely

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

    Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing by Helena A. Yu, Maria E. Arcila, Matthew D. Hellmann, Mark G. Kris, Marc Ladanyi, Gregory J. Riely

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Acquired Resistance of<i>EGFR-</i>Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor

    Acquired Resistance of<i>EGFR-</i>Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor by Helena A. Yu, Shaozhou K. Tian, Alexander Drilon, Laetitia Borsu, Gregory J. Riely, Maria E. Arcila, Marc Ladanyi

    Published 2015
    Get full text
    Carta
    Save to List
    Saved in:
  14. 14
    Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis

    Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis by André L. Moreira, Helen Won, Robert McMillan, James Huang, Gregory J. Riely, Marc Ladanyi, Michael F. Berger

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with <i>EGFR</i>-Mutant Lung Adenocarcinoma

    Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with <i>EGFR</i>-Mutant Lung Adenocarcinoma by James Bean, Gregory J. Riely, Marissa N. Balak, Jenifer L. Marks, Marc Ladanyi, Vincent A. Miller, William Pao

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR -Mutant Lung Adenocarcinomas with Acquired Resistance to Erlotinib

    A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR -Mutant Lung Adenocarcinomas with Acquired Resistance to Erlotinib by Helena A. Yu, Leslie Perez, Qing Chang, Sizhi Paul Gao, Mark G. Kris, Gregory J. Riely, Jacqueline Bromberg

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens

    Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens by Carlie Sigel, André L. Moreira, William D. Travis, Maureen F. Zakowski, Raymond H. Thornton, Gregory J. Riely, Natasha Rekhtman

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Insulin-Like Growth Factor-1 Receptor Expression in Thymic Malignancies

    Insulin-Like Growth Factor-1 Receptor Expression in Thymic Malignancies by Nicolas Girard, Julie Teruya‐Feldstein, Eden C. Payabyab, Gregory J. Riely, Valerie W. Rusch, Mark G. Kris, Maureen F. Zakowski

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

    Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain by William Pao, Vincent A. Miller, Katerina Politi, Gregory J. Riely, Romel Somwar, Maureen F. Zakowski, Mark G. Kris, Harold Varmus

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Association of <i>KRAS</i> and <i>EGFR</i> mutations with survival in patients with advanced lung adenocarcinomas

    Association of <i>KRAS</i> and <i>EGFR</i> mutations with survival in patients with advanced lung adenocarcinomas by Melissa L. Johnson, Camelia S. Sima, Jamie E. Chaft, Paul K. Paik, William Pao, Mark G. Kris, Marc Ladanyi, Gregory J. Riely

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: